Chapters authored
Isolation, Activation, and Mechanism of Action of Platelet-Rich Plasma and Its Applications for Joint Repair
Platelet-Rich Plasma (PRP) is a biologic therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. This technology provides a controlled drug delivery system of growth factors suitable for regenerative medicine. The biological effects of PRP mimic and influence biological processes such as inflammation, analgesia, and cell stimulation, providing this therapy with promising therapeutic potential. All these processes participate in maintenance, correct function, and homeostasis of the joint, where all tissues are involved. Alterations in one joint element have impact on the rest, outstanding the cellular and molecular interaction between the cartilage and subchondral bone. Therefore, the joint is an optimal therapeutic target for PRP therapy, which favors biological environment for joint repair. This chapter collects the basic concepts of joint function and the biological processes that participate in its degeneration, the definition and obtention of PRP, as well as its therapeutic potential and clinical translation.
Part of the book: Regenerative Medicine
New Formulations of Platelet-Rich Plasma: The Relevance of Extraplatelet Molecules
Platelet-rich plasma (PRP) is a biological product with regenerative capacity. It is used in different fields of medicine such as traumatology, dentistry and dermatology, among others. Classically, PRP has been obtained by centrifugation, which generates a plasma enriched in platelets and their components compared to basal levels. However, this process does not enrich all the biomolecules present outside the platelets. Recently, different collection systems have been developed based on different processes such as filtration, sedimentation, ultrasound, microfluidics or water absorption. These systems often provide a more efficient collection in terms of enrichment or speed of collection. Importantly, some of them also favor the enrichment of extraplatelet components. This is potentially an advantage over other systems, given that extraplatelet factors such as IGF-1 or HGF have been reported to play a key role in contributing to the regenerative capacity of PRP.
Part of the book: Wound Healing - New Frontiers and Strategies [Working title]